BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21112036)

  • 1. Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cells.
    Valent P; Cerny-Reiterer S; Herrmann H; Mirkina I; George TI; Sotlar K; Sperr WR; Horny HP
    Best Pract Res Clin Haematol; 2010 Sep; 23(3):369-78. PubMed ID: 21112036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of differentiation- and activation-linked cell surface antigens on cultured mast cell progenitors.
    Schernthaner GH; Hauswirth AW; Baghestanian M; Agis H; Ghannadan M; Worda C; Krauth MT; Printz D; Fritsch G; Sperr WR; Valent P
    Allergy; 2005 Oct; 60(10):1248-55. PubMed ID: 16134990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD203c is overexpressed on neoplastic mast cells in systemic mastocytosis and is upregulated upon IgE receptor cross-linking.
    Hauswirth AW; Escribano L; Prados A; Nuñez R; Mirkina I; Kneidinger M; Florian S; Sonneck K; Vales A; Schernthaner GH; Sanchez-Muñoz L; Sperr WR; Bühring HJ; Orfao A; Valent P
    Int J Immunopathol Pharmacol; 2008; 21(4):797-806. PubMed ID: 19144265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of histidine decarboxylase in neoplastic mast cells in patients with systemic mastocytosis.
    Krauth MT; Agis H; Aichberger KJ; Simonitsch-Klupp I; Müllauer L; Mayerhofer M; Böhm A; Horny HP; Valent P
    Hum Pathol; 2006 Apr; 37(4):439-47. PubMed ID: 16564918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
    Jordan JH; Walchshofer S; Jurecka W; Mosberger I; Sperr WR; Wolff K; Chott A; Bühring HJ; Lechner K; Horny HP; Valent P
    Hum Pathol; 2001 May; 32(5):545-52. PubMed ID: 11381374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of normal and neoplastic human mast cells for expression of CD172a (SIRPalpha), CD47, and SHP-1.
    Florian S; Ghannadan M; Mayerhofer M; Aichberger KJ; Hauswirth AW; Schernthaner GH; Printz D; Fritsch G; Böhm A; Sonneck K; Krauth MT; Müller MR; Sillaber C; Sperr WR; Bühring HJ; Valent P
    J Leukoc Biol; 2005 Jun; 77(6):984-92. PubMed ID: 15784688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of short term in vitro cultured human mast cells from different progenitors - Peripheral blood-derived progenitors generate highly mature and functional mast cells.
    Andersen HB; Holm M; Hetland TE; Dahl C; Junker S; Schiøtz PO; Hoffmann HJ
    J Immunol Methods; 2008 Jul; 336(2):166-74. PubMed ID: 18538784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell surface membrane antigen phenotype of human gastrointestinal mast cells.
    Krauth MT; Majlesi Y; Florian S; Bohm A; Hauswirth AW; Ghannadan M; Wimazal F; Raderer M; Wrba F; Valent P
    Int Arch Allergy Immunol; 2005 Oct; 138(2):111-20. PubMed ID: 16179791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis, clinical features, and treatment advances in mastocytosis.
    Pardanani A; Akin C; Valent P
    Best Pract Res Clin Haematol; 2006; 19(3):595-615. PubMed ID: 16781490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIT polymorphisms and mutations determine responses of neoplastic mast cells to bafetinib (INNO-406).
    Peter B; Hadzijusufovic E; Blatt K; Gleixner KV; Pickl WF; Thaiwong T; Yuzbasiyan-Gurkan V; Willmann M; Valent P
    Exp Hematol; 2010 Sep; 38(9):782-91. PubMed ID: 20685234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mastocytosis, classification, biological diagnosis and therapy].
    Arock M
    Ann Biol Clin (Paris); 2004; 62(6):657-69. PubMed ID: 15563424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical assessment of CD25 is equally sensitive and diagnostic in mastocytosis compared to flow cytometry.
    Baumgartner C; Sonneck K; Krauth MT; Kneidinger M; Födinger M; Hauswirth AW; Müllauer L; Valent P
    Eur J Clin Invest; 2008 May; 38(5):326-35. PubMed ID: 18363719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of neoplastic human mast cells by tryptase-immunoelectron microscopy.
    Samorapoompichit P; Schernthaner GH; Worda C; Wimazal F; Krauth MT; Sperr WR; Valent P
    Histopathology; 2006 Feb; 48(3):247-57. PubMed ID: 16430471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia.
    Escribano L; Orfao A; Villarrubia J; Martín F; Madruga JI; Cuevas M; Velasco JL; Rios A; San Miguel JF
    Cytometry; 1997 Apr; 30(2):98-102. PubMed ID: 9149916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation.
    Beghini A; Cairoli R; Morra E; Larizza L
    Blood Cells Mol Dis; 1998 Jun; 24(2):262-70. PubMed ID: 9714703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V.
    Böhm A; Sonneck K; Gleixner KV; Schuch K; Pickl WF; Blatt K; Peter B; Herrmann H; Schernthaner GH; Pehamberger H; Rabitsch W; Sperr WR; Valent P
    Exp Hematol; 2010 Sep; 38(9):744-55. PubMed ID: 20553795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
    Valent P; Sperr WR; Schwartz LB; Horny HP
    J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the C5a receptor (CD88) on synovial mast cells in patients with rheumatoid arthritis.
    Kiener HP; Baghestanian M; Dominkus M; Walchshofer S; Ghannadan M; Willheim M; Sillaber C; Graninger WB; Smolen JS; Valent P
    Arthritis Rheum; 1998 Feb; 41(2):233-45. PubMed ID: 9485081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.
    Hahn HP; Hornick JL
    Am J Surg Pathol; 2007 Nov; 31(11):1669-76. PubMed ID: 18059223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.